Wright Eclipses Zacks Estimate

Wright Medical Group, Inc. (WMGI - Analyst Report) reported third-quarter earnings per share of 19 cents, surpassing the Zacks Consensus Estimate of 9 cents. The company had earned 19 cents per share in the year-ago quarter.
 
Sales
 
Net sales in the reported quarter increased 6% year over year to $117.7 million. Growth was fueled by strong demand for the company’s extremity, hip and knee products that increased 18%, 7%, and 5% year over year, respectively. This was partly offset by lower biologics sales that declined 4% year over year.
 
On a geographic basis, the U.S. contributed approximately 63% to total revenues and increased 4% year over year. International sales increased 9% year over year.
 
Margins
 
Gross margin declined 170 basis points (bps) year over year to 69.5% due to higher cost of goods sold. Selling, general and administrative expenses as a percentage of sales declined 160 bps year over year to 54.1%. Research and development expenses as a percentage of sales declined 20 bps year over year to 7.3%.
 
Wright was able to considerably lower its operating expenses as a percentage of sales. This resulted in higher operating margin that increased 80 bps year over year to 7%.
 
Balance Sheet
 
Wright ended the quarter with cash, cash equivalents and marketable securities of approximately $161.7 million, an increase of roughly 11% in the first nine months of the year.
 
Guidance
 
Wright has provided guidance for the fourth quarter and fiscal 2009. For the fourth quarter, net sales are estimated between $122 and $127 million, representing an increase of roughly 2% to 6% from the year-ago period. Earnings per share is expected in the range of 22 to 26 cents.
 
For fiscal 2009, net sales should range between $480 and $485 million, increasing approximately 3% to 4% year over year. Earnings per share should be in the range of 80 to 84 cents.
 
Wright Medical is a global orthopedic devices company specializing in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. The orthopedic industry is highly competitive, and Wright Medical faces challenges from large players, such as Zimmer Holdings Inc. (ZMH - Analyst Report), Stryker Corp. (SYK - Analyst Report), Johnson & Johnson/De Puy (JNJ - Analyst Report), Smith & Nephew plc. (SNN - Snapshot Report) and Biomet.

Read the full analyst report on WMGI

Read the full analyst report on ZMH

Read the full analyst report on SYK

Read the full analyst report on JNJ

Read the full analyst report on SNN